Relx Plc (NYSE:RELX) Shares Bought by NewEdge Advisors LLC

NewEdge Advisors LLC lifted its stake in Relx Plc (NYSE:RELX - Free Report) by 19.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,900 shares of the technology company's stock after purchasing an additional 6,616 shares during the quarter. NewEdge Advisors LLC's holdings in Relx were worth $1,812,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. CENTRAL TRUST Co grew its stake in shares of Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after acquiring an additional 529 shares during the period. Versant Capital Management Inc purchased a new position in Relx during the fourth quarter worth $31,000. Sierra Ocean LLC purchased a new position in shares of Relx during the 4th quarter worth about $43,000. Brown Brothers Harriman & Co. boosted its stake in shares of Relx by 218.5% during the 4th quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares during the period. Finally, Private Trust Co. NA boosted its position in Relx by 19.2% in the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after buying an additional 199 shares during the period. Hedge funds and other institutional investors own 15.02% of the company's stock.

Relx Stock Performance

NYSE RELX traded down $0.18 on Monday, reaching $53.37. The stock had a trading volume of 589,217 shares, compared to its average volume of 709,219. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. Relx Plc has a 12-month low of $40.77 and a 12-month high of $53.56. The business's 50-day moving average price is $49.59 and its 200 day moving average price is $48.29. The stock has a market cap of $98.78 billion, a P/E ratio of 28.69, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84.

Relx Increases Dividend

The business also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be paid a dividend of $0.5586 per share. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, May 9th. This is a boost from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio is 59.68%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. StockNews.com lowered shares of Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. Morgan Stanley restated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. Redburn Atlantic began coverage on Relx in a research note on Wednesday, January 8th. They set a "buy" rating for the company. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Finally, The Goldman Sachs Group started coverage on Relx in a report on Wednesday, March 26th. They issued a "buy" rating on the stock. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy".

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.